Listed pharmaceutical company The Ibn Sina Pharmaceutical Industry PLC has declared a 77% cash dividend for its shareholders for the financial year ended June 30, 2026.
The decision was taken at a meeting of the company’s Board of Directors held on Wednesday, September 30, 2026, where the board reviewed and approved the audited financial statements for the latest financial year.
According to company sources, the dividend is entirely in cash. The company had paid a 64% cash dividend to shareholders for the previous financial year.
The company reported consolidated earnings per share (EPS) of Tk 25.43 for FY2025-26, compared with Tk 20.27 in the previous year.
Its cash flow per share stood at Tk 37.95, up from Tk 23.16 a year earlier.
As of June 30, 2026, the company’s net asset value per share (NAVPS) was Tk 144.56.
The company’s Annual General Meeting (AGM) will be held digitally on November 23 at 9:30am. The record date has been set for October 26, 2026.
